Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jun 3;31(12):3274–3288. doi: 10.1007/s11095-014-1417-0

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2014

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

PMC Copyright notice

Fig. 9 — OD15 and MF66 magnetic hyperthermia treatment did not alter the blood composition, indicating a good biotolerability. The number of white blood cells (*10³*μl⁻¹), red blood cells (*10⁶*μl⁻¹), and the amount of hemoglobin (g*dl⁻¹) are displayed for the magnetic hyperthermia treatment and the three control groups at 0 day, 14 days and 28 days after first hyperthermia. Black dashed lines refer to reference values (Harlan Laboratories, Venray, The Netherlands; http://www.harlan.com). MDA-MB-231 xenografts treated with MF66 (a) or OD15 (b). BxPC-3 xenografts treated with MF66 (c) or OD15 (d). Error bars indicate standard deviations. AMF alternating magnetic field, MNP magnetic nanoparticles.